The patient carries a heterozygous splice site mutation in the CSF1R gene (c.2654 + 1G>A, NM_005211.3), accompanied by progressive cognitive decline and a CSF biomarker profile suggesting Alzheimer’s disease-related changes, with no white matter abnormalities detected on the DWI sequence. Here, CSF1R is linked to early-onset autosomal dominant Alzheimer disease.